| Literature DB >> 32187526 |
Lifeng Yang1, Juan Carlos Garcia Canaveras1, Zihong Chen1, Lin Wang1, Lingfan Liang2, Cholsoon Jang1, Johannes A Mayr3, Zhaoyue Zhang1, Jonathan M Ghergurovich4, Le Zhan5, Shilpy Joshi5, Zhixian Hu5, Melanie R McReynolds1, Xiaoyang Su6, Eileen White7, Raphael J Morscher8, Joshua D Rabinowitz9.
Abstract
NADH provides electrons for aerobic ATP production. In cells deprived of oxygen or with impaired electron transport chain activity, NADH accumulation can be toxic. To minimize such toxicity, elevated NADH inhibits the classical NADH-producing pathways: glucose, glutamine, and fat oxidation. Here, through deuterium-tracing studies in cultured cells and mice, we show that folate-dependent serine catabolism also produces substantial NADH. Strikingly, when respiration is impaired, serine catabolism through methylene tetrahydrofolate dehydrogenase (MTHFD2) becomes a major NADH source. In cells whose respiration is slowed by hypoxia, metformin, or genetic lesions, mitochondrial serine catabolism inhibition partially normalizes NADH levels and facilitates cell growth. In mice with engineered mitochondrial complex I deficiency (NDUSF4-/-), serine's contribution to NADH is elevated, and progression of spasticity is modestly slowed by pharmacological blockade of serine degradation. Thus, when respiration is impaired, serine catabolism contributes to toxic NADH accumulation.Entities:
Keywords: MTHFD2; NAD; NADH; SHMT2; complex I inhibitor; hypoxia; methylene tetrahydrofolate dehydrogenase; mitochondrial disease; redox; respiration inhibition; serine catabolism; serine hydroxymethyltransferase
Year: 2020 PMID: 32187526 PMCID: PMC7397714 DOI: 10.1016/j.cmet.2020.02.017
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287